Clinicopathological and Molecular Profile of Sellar Neurocytoma
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae260 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Yulou Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China. Hauptthemen laut MEDLINE: Neurocytoma, Pituitary Neoplasms, Sella Turcica. Die Arbeit nennt 16 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To investigate the clinical features, imaging characteristics, and molecular profile of sellar neurocytoma (SN).
Methods
Clinical, imaging, and pathological features of 11 cases of SN were retrospectively analyzed. Electron microscopy was performed in 5 cases. Molecular features were detected in tumor tissue by RNA sequencing, quantitative polymerase chain reaction, and immunohistochemistry.
Results
The clinical features of SN patients showed a high incidence of hyponatremia (73%, 8/11), and the tumors tended to invade the lateral side of the saddle area from preoperative imaging analysis. The tumors had positive NeuN, synaptophysin, neurofilament, somatostatin receptor 2 (SSTR2) immunohistochemistry staining. Tumor transcriptomic analysis suggested a new LMCD1-AS1:GRM7-AS1 fusion gene event and increased expression of 10 hypothalamus-secreted hormones in SN. Fifteen differentially expressed genes were verified for quantitative polymerase chain reaction verification. SSTR2 has been verified by immunohistochemistry.
Conclusion
Hyponatremia is the dominant clinical features of SN. Preoperative imaging suggests that growth toward the dorsal region is the imaging feature of SN. SSTR2 expression and LMCD1-AS1:GRM7-AS1 fusion gene event expected to become a new molecular marker for SN. Somatostatin receptor ligand therapy may be a potential therapy for SN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
ORCID-Profile: Chuzhong Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Guo, J., Cheng, J., Fang, Q., Wang, D., Xie, W., & Li, C. (2025). Clinicopathological and Molecular Profile of Sellar Neurocytoma. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae260
Vancouver
Liu Y, Guo J, Cheng J, Fang Q, Wang D, Xie W, et al. Clinicopathological and Molecular Profile of Sellar Neurocytoma. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae260
BibTeX
@article{Liu2025,
author = {Liu, Yulou and Guo, Jing and Cheng, Jianhua and Fang, Qiuyue and Wang, Dawei and Xie, Weiyan and Li, Chuzhong},
title = {Clinicopathological and Molecular Profile of Sellar Neurocytoma},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae260}
}
EUVIMED